Skip to main content
EssilorLuxottica logo

EssilorLuxottica — Investor Relations & Filings

Ticker · EL ISIN · FR0014007HJ5 LEI · 549300M3VH1A3ER1TB49 PA Manufacturing
Filings indexed 1,137 across all filing types
Latest filing 2025-11-06 Regulatory Filings
Country FR France
Listing PA EL

About EssilorLuxottica

https://www.essilorluxottica.com/

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, prescription frames, and sunglasses. The company operates a vertically integrated business model, managing a comprehensive portfolio of proprietary and licensed eyewear and vision care brands. Its activities encompass the production of advanced vision care products, including lenses and optical instruments, as well as a wide range of eyewear. EssilorLuxottica distributes its products through a global network of wholesale and retail channels, serving consumers with solutions for their vision needs and personal style.

Recent filings

Filing Released Lang Actions
EssilorLuxottica étend sa plateforme de solutions de gestion de la myopie avec les verres Essilor Stellest 2.0, des lunettes connectées et une solution innovante pour adresser la pré-myopie
Regulatory Filings Classification · 95% confidence The document is a press release issued by EssilorLuxottica announcing the expansion of their 'Essilor Stellest' product line, specifically the launch of 'Stellest 2.0' lenses and smartglasses at the China International Import Expo. It details product features, clinical study references, and strategic business updates regarding their med-tech portfolio. It does not constitute a formal financial report (10-K, IR), a regulatory filing, or a shareholder meeting document. As it is a corporate announcement regarding product innovation and business development, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-11-06 French
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
Regulatory Filings Classification · 95% confidence The document is a press release issued by EssilorLuxottica announcing the expansion of their 'Essilor Stellest' myopia management platform. It details new product features, clinical trial results, and market availability. It does not contain financial statements, earnings results, or regulatory filings, but rather serves as a corporate communication regarding product innovation and business development. As it does not fit into specific categories like 10-K, ER, or IR, it falls under the general regulatory/corporate announcement category.
2025-11-06 English
EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group
Earnings Release Classification · 95% confidence The document is a detailed quarterly financial update from EssilorLuxottica for Q3/9M 2025. It provides comprehensive revenue breakdowns by segment, region, and channel, along with management commentary on business performance, acquisitions, and product innovation. It is not a brief announcement (RPA) but a substantive report of financial results. Given the focus on quarterly performance and management's detailed explanation of trends, it fits the definition of an Interim/Quarterly Report. Q3 2025
2025-10-16 English
EssilorLuxottica: Chiffre d'affaires T3/9M 2025 - Chiffre d'affaires en hausse de 11,7 % au T3, meilleure performance trimestrielle du Groupe depuis sa création
Earnings Release Classification · 100% confidence The document is a detailed quarterly financial results announcement for EssilorLuxottica for the third quarter (T3) and the first nine months (9M) of 2025. It includes consolidated revenue figures, segment-by-segment analysis (Professional Solutions and Direct to Consumer), regional performance breakdowns (North America, EMEA, APAC, Latin America), and management commentary. It is not a full annual report (10-K) nor a simple publication announcement (RPA), but rather the primary release of quarterly financial performance data. Q3 2025
2025-10-16 French
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
M&A Activity Classification · 100% confidence The document is a press release announcing the acquisition of Ikerian AG (RetinAI) by EssilorLuxottica. It details the strategic rationale, quotes from leadership, and provides background information on both companies. This falls under M&A activity (mergers and acquisitions).
2025-10-15 English
EssilorLuxottica acquiert RetinAI, accélérant dans les solutions transformatrices de santé de l’œil portées par l'IA et la data
M&A Activity Classification · 100% confidence The document is a press release announcing the acquisition of Ikerian AG (RetinAI) by EssilorLuxottica. It details the strategic rationale, the nature of the business being acquired, and includes quotes from the CEOs of both companies. This falls under M&A activity (mergers and acquisitions).
2025-10-15 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.